- Home
- SHMD vs BDTX Comparison
SHMD vs BDTX Comparison
Compare SHMD & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- BDTX
- Stock Information
- Founded
- SHMD 1864
- BDTX 2014
- Country
- SHMD Germany
- BDTX United States
- Employees
- SHMD N/A
- BDTX N/A
- Industry
- SHMD
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHMD
- BDTX Health Care
- Exchange
- SHMD Nasdaq
- BDTX Nasdaq
- Market Cap
- SHMD 209.7M
- BDTX 220.3M
- IPO Year
- SHMD N/A
- BDTX 2020
- Fundamental
- Price
- SHMD $5.79
- BDTX $4.60
- Analyst Decision
- SHMD
- BDTX Strong Buy
- Analyst Count
- SHMD 0
- BDTX 5
- Target Price
- SHMD N/A
- BDTX $10.40
- AVG Volume (30 Days)
- SHMD 620.4K
- BDTX 852.4K
- Earning Date
- SHMD 01-01-0001
- BDTX 11-06-2025
- Dividend Yield
- SHMD N/A
- BDTX N/A
- EPS Growth
- SHMD N/A
- BDTX N/A
- EPS
- SHMD N/A
- BDTX 0.38
- Revenue
- SHMD $85,165,542.00
- BDTX $70,000,000.00
- Revenue This Year
- SHMD N/A
- BDTX N/A
- Revenue Next Year
- SHMD N/A
- BDTX N/A
- P/E Ratio
- SHMD N/A
- BDTX $12.12
- Revenue Growth
- SHMD N/A
- BDTX N/A
- 52 Week Low
- SHMD $1.86
- BDTX $1.20
- 52 Week High
- SHMD $6.07
- BDTX $4.62
- Technical
- Relative Strength Index (RSI)
- SHMD 78.11
- BDTX 66.94
- Support Level
- SHMD $4.49
- BDTX $3.79
- Resistance Level
- SHMD $5.22
- BDTX $4.21
- Average True Range (ATR)
- SHMD 0.57
- BDTX 0.24
- MACD
- SHMD 0.14
- BDTX 0.04
- Stochastic Oscillator
- SHMD 96.92
- BDTX 97.52
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.